LexDanaLexDanabeta
Inventor

Marc Ferrer

Inventor
Potomac, MD, US

Overview

2→
Patents
2017–2019
Patent span
Human necessities
Primary field (CPC A)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds33%
A61KPreparations for medical, dental or toiletry purposes17%
Y02ATechnologies for adaptation to climate change17%
PatentTitleYear
10,202,367Heterocyclic compounds and methods of use thereof20199,550,742'11-OXO-10,11-dihydrodibenzo[B,F][1,4]thiazepine S-oxide derivatives and their use as dopamine D2 receptor antagonists'2017

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2017–2019Patents assigned to US HEALTH (2)· patent assignee history
2017Patents assigned to THE US SECRETARY DEPT OF HEALTH AND HUMAN (1)· patent assignee history
2017–2019Based in Potomac, MD, US· patent location history
2019Patents assigned to UNIV KANSAS (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
US HEALTH22017–2019
THE US SECRETARY DEPT OF HEALTH AND HUMAN12017
UNIV KANSAS12019
Locations
LocationPatentsSpan
Potomac, Maryland, US22017–2019